Wave Life Sciences Ltd (NASDAQ: WVE) is 199.01% higher on its value in year-to-date trading and has touched a low of $3.50 and a high of $16.74 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The WVE stock was last observed hovering at around $14.99 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $15.10, the stock is 2.89% and 22.68% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.62 million and changing 0.73% at the moment leaves the stock 105.46% off its SMA200. WVE registered 188.17% gain for a year compared to 6-month gain of 144.34%. The firm has a 50-day simple moving average (SMA 50) of $12.3054 and a 200-day simple moving average (SMA200) of $7.34855.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 5.45% loss in the last 1 month and extending the period to 3 months gives it a 163.07%, and is 5.23% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.39% over the week and 6.91% over the month.
Wave Life Sciences Ltd (WVE) has around 268 employees, a market worth around $2.32B and $53.61M in sales. Profit margin for the company is -265.84%. Distance from 52-week low is 331.43% and -9.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-84.19%).
The EPS is expected to shrink by -113.04% this year.
Wave Life Sciences Ltd (WVE) Top Institutional Holders
215.0 institutions hold shares in Wave Life Sciences Ltd (WVE), with institutional investors hold 92.38% of the company’s shares. The shares outstanding are 119.16M, and float is at 118.14M with Short Float at 5.46%. Institutions hold 78.49% of the Float.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 18.2 million shares valued at $90.83 million. The investor’s holdings represent 14.0527% of the WVE Shares outstanding. As of 2024-06-30, the second largest holder is MAVERICK CAPITAL LTD with 7.67 million shares valued at $38.27 million to account for 5.9211 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.74 million shares representing 5.2128% and valued at over $33.63 million, while M28 CAPITAL MANAGEMENT LP holds 4.7593 of the shares totaling 6.16 million with a market value of $30.76 million.
Wave Life Sciences Ltd (WVE) Insider Activity
The most recent transaction is an insider sale by BOLNO PAUL, the company’s President and CEO. SEC filings show that BOLNO PAUL sold 50,000 shares of the company’s common stock on Nov 25 ’24 at a price of $15.00 per share for a total of $0.75 million. Following the sale, the insider now owns 0.22 million shares.
Still, SEC filings show that on Nov 15 ’24, BOLNO PAUL (President and CEO) disposed off 51,234 shares at an average price of $14.32 for $0.73 million. The insider now directly holds 217,351 shares of Wave Life Sciences Ltd (WVE).
